“Even though we keep on being centered on the possible resubmission of our M207 New Drug Application, we also carry on to pursue non-dilutive and partnership possibilities to broaden the possible use of our technologies.” Finish-to-end encryption ensures that just the sender and recipients maintain the keys to encrypt and decrypt https://httpswwwzosanopharmacomte09752.blogolenta.com/33707745/https-www-zosanopharma-com-technology-an-overview